logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Medexus Pharmaceuticals Inc.

MDP.TO

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intrā€¦ read more

Healthcare

Drug Manufacturersā€”Specialty & Generic

9 years

CAD

Exclusive to Premium users

Price

per share adjusted in CAD

$2.95

Price

+7.27%

$0.20

$2.75

Previous Close

$2.79

Open

Premium

52w Discount
Market Cap

$95.162m

Small

Price/Earnings

26.8x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$108.332m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

$2.247m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

$0.09

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$52.143m

$171.838m

Assets

$119.695m

Liabilities

$37.178m

Debt
Debt to Assets

21.6%

2.2x

Debt to EBITDA
Free Cash Flow

$21.308m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
ā†‘ TopSummaryPriceFinancials
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.